SOPHiA GENETICS Investor Relations Material
Latest events
Q2 2025
SOPHiA GENETICS
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SOPHiA GENETICS SA
Access all reports
SOPHiA GENETICS SA is a health technology company that provides a cloud-based analytics platform for data-driven medicine. Its solutions support genomic and radiomic data interpretation for clinical and research purposes, primarily in oncology, hereditary disorders, and infectious diseases. The company serves hospitals, laboratories, and pharmaceutical companies. It is headquartered in Saint-Sulpice, Switzerland, and its shares are listed on the NASDAQ.
Key slides for SOPHiA GENETICS SA
Q2 2025
SOPHiA GENETICS SA
Q2 2025
SOPHiA GENETICS SA
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
SOPH
Country
🇺🇸 United States